1. Home
  2. PAX vs NTLA Comparison

PAX vs NTLA Comparison

Compare PAX & NTLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Patria Investments Limited

PAX

Patria Investments Limited

HOLD

Current Price

$11.17

Market Cap

1.8B

Sector

Finance

ML Signal

HOLD

Logo Intellia Therapeutics Inc.

NTLA

Intellia Therapeutics Inc.

HOLD

Current Price

$11.38

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PAX
NTLA
Founded
1988
2014
Country
Cayman Islands
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.7B
IPO Year
2020
2016

Fundamental Metrics

Financial Performance
Metric
PAX
NTLA
Price
$11.17
$11.38
Analyst Decision
Buy
Buy
Analyst Count
2
23
Target Price
$18.00
$20.02
AVG Volume (30 Days)
796.0K
5.5M
Earning Date
05-05-2026
05-07-2026
Dividend Yield
4.81%
N/A
EPS Growth
N/A
27.43
EPS
N/A
N/A
Revenue
N/A
$67,671,000.00
Revenue This Year
$12.99
N/A
Revenue Next Year
$16.52
$62.75
P/E Ratio
$25.65
N/A
Revenue Growth
N/A
16.92
52 Week Low
$10.56
$7.95
52 Week High
$17.80
$28.24

Technical Indicators

Market Signals
Indicator
PAX
NTLA
Relative Strength Index (RSI) 50.38 32.39
Support Level $11.04 $8.59
Resistance Level $11.38 $15.52
Average True Range (ATR) 0.24 1.03
MACD 0.04 -0.65
Stochastic Oscillator 60.75 5.88

Price Performance

Historical Comparison
PAX
NTLA

About PAX Patria Investments Limited

Patria Investments Ltd is an alternative asset management firm specializing in resilient sectors across select regions. It seeks to provide world-wide and Latin American investors with attractive investment products that allows portfolio diversification and consistent returns. The group promotes inclusive and sustainable development in the Asset Classes: Private Equity, Private Equity Solutions, Credit, Real Estate, Infrastructure, and Public Equities Main sectors: Agribusiness, Power & Energy, Healthcare, Logistics & Transportations, Food & Beverage and Digital & Tech Services Investment Regions.

About NTLA Intellia Therapeutics Inc.

Intellia Therapeutics is a gene-editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. Intellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple gene editing approaches using in vivo and ex vivo therapies to address diseases with high unmet medical needs, including ATTR amyloidosis, hereditary angioedema, sickle cell disease, and immuno-oncology. Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis.

Share on Social Networks: